Trade Summary

3 weeks ago, Vivo Opportunity, LLC, serving as 10% owner Owner at InMed Pharmaceuticals Inc. (INM), purchased 249,227 shares at $1.57 per share, for a total transaction value of $391,554.51. Following this transaction, Vivo Opportunity, LLC now holds 72,535 shares of INM.

The trade was executed on Wednesday, May 20, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 11, 2026 (accepted Jun 10, 9:14 PM ET), 22 days after the trade was made.

InMed Pharmaceuticals Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.